Please wait while the formulary information is being retrieved.
VYVGART (efgartigimod alfa-fcab)
- AChR antibody positive generalized myasthenia gravis
20 mg/mL intravenous solution
- Infuse 10 mg/kg over 1 hour(s) by intravenous route once weekly for 4Weeks
Default screening record
- Infuse 10 mg/kg over 1 hour(s) by intravenous route once weekly
- Infuse 10 mg/kg over 1 hour(s) by intravenous route once weekly for 4Weeks
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Severe infection
Severe
Moderate
- None
VYVGART (efgartigimod alfa-fcab)
- AChR antibody positive generalized myasthenia gravis
- None
- Headache disorder
- Upper respiratory infection
- Urinary tract infection
More Frequent
Severe
Less Severe
- None
- Myalgia
- Paresthesia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Angioedema
- Dyspnea
Less Severe
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Efgartigimod alfa-fcab
Safety and effectiveness not established in pediatric patients < 18 years.
- 1 Day – 18 Years
- Safety and effectiveness not established in pediatric patients < 18 years.
Efgartigimod Alfa-fcab
- Severity Level:
2
- Additional Notes: Insuff human data avail; consider maternal benefit vs neonatal risk
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Efgartigimod Alfa-fcab
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| AchR antibody positive generalized myasthenia gravis | |
| G70.0 | Myasthenia gravis |
| G70.00 | Myasthenia gravis without (acute) exacerbation |
| G70.01 | Myasthenia gravis with (acute) exacerbation |
| 0-9 | A-Z |
|---|---|
| G70.0 | Myasthenia gravis |
| G70.00 | Myasthenia gravis without (acute) exacerbation |
| G70.01 | Myasthenia gravis with (acute) exacerbation |
Formulary Reference Tool